Table 3
Open in new tab

Deterministic sensitivity analyses

ScenarioValueCost per gained QALY (€)
Time horizon5 years78 049
10 years19 092
15 years7855
Discount rate0%34
5%7874
Prevalence of unknown AF (in 75-years-old individuals)1%26 892
5%373
Yearly spontaneous detection of AF0%2590
10%6232
OAC adherence50%12 423
100%3661
CHA2DS2-VASc (mean)2.516 176
4.5–628
Asymptomatic AF stroke risk (in relation to symptomatic AF)+25%−1467
−25%15 090
−50%40 422
Warfarin (used as OAC)4040
Discontinuation rate OAC20% year 1 (decreases yearly with 30%)10 175
ScenarioValueCost per gained QALY (€)
Time horizon5 years78 049
10 years19 092
15 years7855
Discount rate0%34
5%7874
Prevalence of unknown AF (in 75-years-old individuals)1%26 892
5%373
Yearly spontaneous detection of AF0%2590
10%6232
OAC adherence50%12 423
100%3661
CHA2DS2-VASc (mean)2.516 176
4.5–628
Asymptomatic AF stroke risk (in relation to symptomatic AF)+25%−1467
−25%15 090
−50%40 422
Warfarin (used as OAC)4040
Discontinuation rate OAC20% year 1 (decreases yearly with 30%)10 175
Table 3
Open in new tab

Deterministic sensitivity analyses

ScenarioValueCost per gained QALY (€)
Time horizon5 years78 049
10 years19 092
15 years7855
Discount rate0%34
5%7874
Prevalence of unknown AF (in 75-years-old individuals)1%26 892
5%373
Yearly spontaneous detection of AF0%2590
10%6232
OAC adherence50%12 423
100%3661
CHA2DS2-VASc (mean)2.516 176
4.5–628
Asymptomatic AF stroke risk (in relation to symptomatic AF)+25%−1467
−25%15 090
−50%40 422
Warfarin (used as OAC)4040
Discontinuation rate OAC20% year 1 (decreases yearly with 30%)10 175
ScenarioValueCost per gained QALY (€)
Time horizon5 years78 049
10 years19 092
15 years7855
Discount rate0%34
5%7874
Prevalence of unknown AF (in 75-years-old individuals)1%26 892
5%373
Yearly spontaneous detection of AF0%2590
10%6232
OAC adherence50%12 423
100%3661
CHA2DS2-VASc (mean)2.516 176
4.5–628
Asymptomatic AF stroke risk (in relation to symptomatic AF)+25%−1467
−25%15 090
−50%40 422
Warfarin (used as OAC)4040
Discontinuation rate OAC20% year 1 (decreases yearly with 30%)10 175
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close